Status:
UNKNOWN
Deploying Novel Imaging Modalities Towards a Three-dimensional (3D) CARDIOvascular PATHology
Lead Sponsor:
Aristotle University Of Thessaloniki
Collaborating Sponsors:
National and Kapodistrian University of Athens
University of Southampton
Conditions:
Coronary Artery Disease
Aortic Valve Disease
Eligibility:
All Genders
18+ years
Brief Summary
The goal of the 3D-CARDIOPATH study is to investigate the potential added value of emerging 3D imaging modalities by imaging ex vivo cardiac specimens (diseased coronary arteries, calcific aortic valv...
Detailed Description
The 3D-CARDIOPATH study aims to provide 3D volumetric insights into well-characterized disease entities such as Coronary artery disease (CAD) and calcific aortic valvular disease (CAVD). Therefore, th...
Eligibility Criteria
Inclusion
- Age \>18 years.
- Patients with sudden cardiac death for coronary artery imaging.
- Patients with STEMI undergoing PCI and thrombus aspiration for thrombus imaging.
- Patients with CAVD undergoing cardiac replacement of calcific aortic valve for valve imaging.
Exclusion
- Patients dying after the execution of their cardiac surgery.
- Patients with altered mental status; unable or unwilling to provide informed consent for specimen imaging and clinical follow-up.
Key Trial Info
Start Date :
September 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 1 2025
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT05975567
Start Date
September 1 2023
End Date
June 1 2025
Last Update
August 4 2023
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.